Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phil Greenfield

Editor

London, UK

After studying engineering, Editor-In-Chief Phil Greenfield started reporting on the medtech sector as a science journalist in 1993, when digital health, TAVR and personalized medicine were pipe dreams. He has since worked across all areas of health-care publishing, as an editor, publisher and principal analyst, and has been responsible for launching intelligence-based products to medtech and pharma clients. Phil has written extensively on topics around diagnostic imaging, IVDs, cardiovascular devices, orthopedics, oncology, wound care, clinical trials and EU reimbursement, and has authored numerous market forecasting reports on subjects ranging from prostate cancer diagnostics and devices to transcatheter embolization systems. Phil has also recently worked as an independent consultant with medtech/healthtech companies and universities assessing markets and product opportunities. A keen cyclist and walker, he lives in Yorkshire, England, where the steep hills help him counterbalance his other loves of food and Belgian beer.


Latest From Phil Greenfield

In A First, FDA Approves Radioembolization Treatment For Liver Cancer In US

Approval for Boston Scientific’s TheraSphere offers further access to the therapy that, until now, has only been available under a humanitarian device exemption.

Approvals Cancer

Exec Chat: Signifier Medical Investing In ‘Daytime-Only Treatments’ And Diagnostics For Sleep Apnea

The UK-based company is seeking to raise a further $100m in 2021 following the recent US clearance of its first product, a daytime-use neurostimulation device for snoring and mild obstructive sleep apnea.

Exec Chat Artificial Intelligence

Cantel Medical Snapped Up By Steris For $3.6Bn

The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.

M & A Commercial

Top 10 R&D Stories Of 2020: The Year Of Diagnostics And Telehealth

One of the few silver linings in a tumultuous year dominated by a global pandemic was the huge boost given to the diagnostics and telehealth sectors. But while new technologies for rapid testing for COVID-19 and remote monitoring tools dominated the headlines, there were also key developments in robotic surgery, early-stage cancer testing and cardiac arrhythmia treatment. Here are Medtech Insight’s most popular R&D stories in 2020.

Research & Development Telehealth

Carmat To Launch Total Artificial Heart In Early 2021

After years of setbacks, the company will launch its device in Europe as a bridge to transplant in heart failure patents.

Research & Development Approvals

UK’s QuantuMDx Invests £11M To Bring Forward Launch Of Rapid, Point-Of-Care DNA Analyzer

The COVID-19 pandemic has accelerated development of another new molecular diagnostic technology.

Coronavirus COVID-19 Research & Development
See All
UsernamePublicRestriction

Register